These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Fadeel B; Garcia-Bennett AE Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497 [TBL] [Abstract][Full Text] [Related]
4. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Tomalia DA; Reyna LA; Svenson S Biochem Soc Trans; 2007 Feb; 35(Pt 1):61-7. PubMed ID: 17233602 [TBL] [Abstract][Full Text] [Related]
5. Unique benefits of nanotechnology to drug delivery and diagnostics. McNeil SE Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949 [TBL] [Abstract][Full Text] [Related]
6. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Al-Jamal WT; Kostarelos K Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415 [TBL] [Abstract][Full Text] [Related]
7. Nanostructure-mediated drug delivery. Hughes GA Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054 [TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanoparticles--properties and prospects for their use in human medicine. Sanvicens N; Marco MP Trends Biotechnol; 2008 Aug; 26(8):425-33. PubMed ID: 18514941 [TBL] [Abstract][Full Text] [Related]
10. Self-ordered nanopore and nanotube platforms for drug delivery applications. Losic D; Simovic S Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles. Shokeen M; Fettig NM; Rossin R Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):267-77. PubMed ID: 18475250 [TBL] [Abstract][Full Text] [Related]
12. Multifunctional nanoparticles for multimodal imaging and theragnosis. Lee DE; Koo H; Sun IC; Ryu JH; Kim K; Kwon IC Chem Soc Rev; 2012 Apr; 41(7):2656-72. PubMed ID: 22189429 [TBL] [Abstract][Full Text] [Related]
14. The immune effects of naturally occurring and synthetic nanoparticles. Chang C J Autoimmun; 2010 May; 34(3):J234-46. PubMed ID: 19995678 [TBL] [Abstract][Full Text] [Related]
15. Review: nanoparticles in drug delivery for the treatment of cancer. Arayne MS; Sultana N Pak J Pharm Sci; 2006 Jul; 19(3):258-68. PubMed ID: 16935836 [TBL] [Abstract][Full Text] [Related]
16. Multifunctional dendritic polymers in nanomedicine: opportunities and challenges. Khandare J; Calderón M; Dagia NM; Haag R Chem Soc Rev; 2012 Apr; 41(7):2824-48. PubMed ID: 22158998 [TBL] [Abstract][Full Text] [Related]
17. Physical and biochemical insights on DNA structures in artificial and living systems. Chen N; Li J; Song H; Chao J; Huang Q; Fan C Acc Chem Res; 2014 Jun; 47(6):1720-30. PubMed ID: 24588263 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology. Ilinskaya AN; Dobrovolskaia MA Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264 [TBL] [Abstract][Full Text] [Related]
19. The growing role of nanotechnology in combating infectious disease. Blecher K; Nasir A; Friedman A Virulence; 2011; 2(5):395-401. PubMed ID: 21921677 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-mediated drug delivery and gene therapy. Jin S; Ye K Biotechnol Prog; 2007; 23(1):32-41. PubMed ID: 17269667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]